1444 Organometallics, Vol. 20, No. 7, 2001
Courtenay and Stephan
Syn th esis of Cp *Ta (NP R3)(η2-C2H4)Cl, R ) t-Bu 10, i-P r
11. These compounds were prepared in a similar fashion, and
thus only one preparation is detailed. To a suspension of 1
(200 mg, 0.313 mmol) in 5 mL of toluene was added EtMgCl
(0.314 mL, 2 M solution in ether) and stirred overnight. The
suspension was filtered, and the solvent evaporated, isolating
the reddish product in 63% yield: 1H NMR (C6D6) δ 2.35 (m,
|J 2H-H| ) 9.0 Hz, |J 3H-H| ) 12.5 Hz, |J 3H-H| ) 9.2 Hz, Ta(η2-
C2H4)), 1.94 (s, 15H, C5(CH3)5), 1.82 (m, |J 3H-H| ) 10.7 Hz,
NMR (CD2Cl2) δ -54.57 (s, 6F), -82.37 (s, 3F), -88.84 (s, 6F).
14: 1H NMR (CD2Cl2) δ 7.25 (m, br, (C6H5)3CCl), 2.44 (s, 15H,
C5(CH3)5), 1.58 (d, |J P-H| ) 14.7 Hz, 27H, PC(CH3)3); 13C{1H}
NMR (CD2Cl2) δ 145.58, 138.29, 131.47, 129.99 (s, (C6H5)3CCl),
128.13 (s, C5(CH3)5), 43.18 (d, |J P-C| ) 37.8 Hz, PC(CH3)3),
29.66 (s, PC(CH3)3), 12.62 (s, C5(CH3)5); 31P{1H} NMR (CD2-
Cl2) δ 74.68 (s); 11B NMR (CD2Cl2) δ -18.84 (s); 19F NMR (CD2-
Cl2) δ -55.78 (s, 8F), -86.45 (t, |J F-F| ) 20.3 Hz, 4F), -90.27
(s, 8F). 15: 1H NMR (CD2Cl2) δ 2.10 (s, 15H, C5(CH3)5), 1.51
(d, |J P-H| ) 14.0 Hz, 27H, PC(CH3)3), 0.44 (s, 9H, Ta-CH3);
13C{1H} NMR (CD2Cl2) δ 150-130 (br, B(C6F5)3), 121.85 (s, C5-
(CH3)5), 58.73 (s, Ta-CH3), 42.43 (d, |J P-C| ) 41.4 Hz, PC(CH3)3),
29.84 (s, PC(CH3)3), 11.86 (s, C5(CH3)5); 31P{1H} NMR (CD2-
Cl2) δ 66.62 (s); 11B NMR (CD2Cl2) δ -17.08 (s); 19F NMR (CD2-
Cl2) δ -55.44 (d, |J F-F| ) 20.0 Hz, 6F), -87.70 (t, |J F-F| ) 20.0
Hz, 3F), -90.23 (t, |J F-F| ) 19.1 Hz, 6F). 16: 1H NMR (CD2-
Cl2) δ 2.45 (m, 3H, PCH(CH3)2) 2.15 (s, 15H, C5(CH3)5), 1.38
(dd, |J P-H| ) 15.9 Hz, |J H-H| ) 7.2 Hz, 18H, PCH(CH3)2), 0.49
(s, 9H, Ta-CH3); 13C{1H} NMR (CD2Cl2) δ 150-130 (br,
B(C6F5)3), 121.68 (s, C5(CH3)5), 57.94 (s, Ta-CH3), 26.48 (d,
|J P-C| ) 54.4 Hz, PCH(CH3)2), 16.84 (s, PCH(CH3)2), 11.69 (s,
C5(CH3)5); 31P{1H} NMR (CD2Cl2) δ 58.30 (s); 11B NMR (CD2-
Cl2) δ -17.12 (s); 19F NMR (CD2Cl2) δ -55.91 (d, |J F-F| ) 20.6
Hz, 6F), -88.12 (t, |J F-F| ) 20.3 Hz, 3F), -90.68 (t, |J F-F| )
18.9 Hz, 6F). 17: 1H NMR (CD2Cl2) δ 2.13 (s, 15H, C5(CH3)5),
1.55 (d |J P-H| ) 14.0 Hz, 27H, PC(CH3)3), 0.48 (s, 6H, Ta-CH3);
13C{1H} NMR (CD2Cl2) δ 121.28 (s, C5(CH3)5), 58.12 (s, Ta-
CH3), 41.86 (d, |J P-C| ) 41.5 Hz, PC(CH3)3), 29.25 (s, PC(CH3)3),
11.25 (s, C5(CH3)5); 31P{1H} NMR (CD2Cl2) δ 66.68 (s); 11B NMR
(CD2Cl2) δ -19.06 (s); 19F NMR (CD2Cl2) δ -55.80 (s, 8F),
-86.46 (t, 18.0 Hz, 4F), -90.29 (s, 8F). 18: 1H NMR (CD2Cl2)
δ 7.30-7.11 (m, 15H, (C6H5)3CCH3) 2.44 (m, 3H, PCH(CH3)2)
2.19 (s, 3H, (C6H5)3CCH3) 2.14 (s, 15H, C5(CH3)5), 1.37 (dd
|J P-H| ) 15.9 Hz, |J H-H| ) 7.2 Hz, 18H, PCH(CH3)2), 0.49 (s,
6H, Ta-CH3); 13C{1H} NMR (CD2Cl2) (partial) δ 149.53, 129.07,
128.20, 126.31 (s(C6H5)3CCH3), 121.52 (s, C5(CH3)5), 57.81 (s,
Ta-CH3), 30.64 (s, (C6H5)3CCH3) 26.32 (d, |J P-C| ) 54.9 Hz,
PCH(CH3)2), 16.73 (s, PCH(CH3)2), 11.61 (s, C5(CH3)5); 31P{1H}
NMR (CD2Cl2) δ 58.28 (s); 11B NMR (CD2Cl2) δ - 18.79 (s);
19F NMR (CD2Cl2) δ - 55.75 (s, 8F), - 86.42 (t, 20.3 Hz, 4F),
|J 2H-H| ) 5.9 Hz, |J 3H-H| ) 9.2 Hz, Ta(η2-C2H4)), 1.68 (m, |J 3
|
H-H
) 10.0 Hz, |J 2H-H| ) 5.9 Hz, |J 3H-H| ) 12.5 Hz, Ta(η2-C2H4)),
1.11 (d, |J P-H| ) 13.1 Hz, 27H, PC(CH3)3), 0.79 (m, |J 3H-H| )
10.0 Hz, |J 3H-H| ) 10.7 Hz, |J 2H-H| ) 9.0 Hz, Ta(η2-C2H4)); 13C-
{1H} NMR (C6D6) δ 111.93 (s, C5(CH3)5), 57.31 (s, Ta(η2-C2H4)),
46.45 (s, Ta(η2-C2H4)), 41.00 (d, |J P-H| ) 46.3 Hz, PC(CH3)3),
29.67 (s, PC(CH3)3), 11.71 (s, C5(CH3)5); 31P{1H} NMR (C6D6)
δ 54.16 (s); 1H NMR (CD2Cl2)(partial) δ 1.88 (s, 15H, C5(CH3)5),
1.36 (d, |J P-H| ) 13.1 Hz, 27H, PC(CH3)3), 0.12 (m, Ta(η2-
C2H4)); 13C{1H} NMR (CD2Cl2) δ 111.98 (s, C5(CH3)5), 55.25(s,
Ta(η2-C2H4)), 45.45 (s, Ta(η2-C2H4)), 41.31 (d, |J P-H| ) 46.3 Hz,
PC(CH3)3), 29.57 (s, PC(CH3)3), 11.37 (s, C5(CH3)5); 31P{1H}
NMR (CD2Cl2) δ 54.85 (s). Anal. Calcd for C24H46ClNPTa: C,
48.36; H, 7.78; N, 2.35. Found: C, 48.57; H, 7.34; N, 2.35. 11:
58% yield. H NMR (C6D6) δ 2.29 (m, Ta(η2-C2H4)), 1.97 (s, 15H,
C5(CH3)5), 1.83 (m, Ta(η2-C2H4)), 1.71 (m, Ta(η2-C2H4)), 1.60
(m, 3H, PCH(CH3)2), 0.84 (dd, |J P-H| ) 14.8 Hz, |J H-H| ) 7.3
Hz, 9H, PCH(CH3)2), 0.83 (obscured, Ta(η2-C2H4)), 0.82 (dd,
|J P-H| ) 14.8 Hz, |J H-H| ) 7.3 Hz, 9H, PCH(CH3)2; 13C{1H}
NMR (C6D6) δ 115.75 (s, C5(CH3)5), 60.37 (s, Ta(η2-C2H4)), 49.90
(s, Ta(η2-C2H4)), 28.92 (d, |J P-H| ) 57.2 Hz, PCH(CH3)2), 20.31
(s, PCH(CH3)2), 15.35 (s, C5(CH3)5); 31P{1H} NMR (C6D6) δ
43.44 (s). Anal. Calcd for C21H40ClNPTa: C, 45.53; H, 7.28;
N, 2.53. Found: C, 45.40; H, 6.91; N, 2.34.
Syn th esis of Cp *Ta (NP t-Bu 3)(η2-C2H4)(CH2CH3), 12. To
a suspension of 10 (200 mg, 0.313 mmol) in 5 mL of toluene
was added EtMgCl (0.470 mL, 2 M solution in ether). The
suspension was stirred overnight, filtered, and evaporated to
dryness, giving the product as an orange, crystalline solid in
60% yield: 1H NMR (tol-d8) δ 2.02 (t, |J H-H| ) 7.6 Hz, Ta-
CH2CH3), 1.90 (s, 15H, C5(CH3)5), 1.71 (m, Ta(η2-C2H4)), 1.49
(m, |J H-H| ) 7.6 Hz, Ta-CH2CH3), 1.08 (m, Ta(η2-C2H4)), 1.08
(d, |J P-H| ) 12.9 Hz, 27H, PC(CH3)3), 0.73 (m, Ta(η2-C2H4)),
0.16 (m, Ta(η2-C2H4)); 13C{1H} NMR (tol-d8) δ 108.28 (s, C5-
(CH3)5), 48.40 (s, Ta(η2-C2H4)), 40.56 (d, |J P-C| ) 47.1 Hz,
PC(CH3)3), 33.17 (s, Ta(η2-C2H4)), 29.39 (s, PC(CH3)3), 27.40
(s, Ta-CH2CH3), 18.08 (s, Ta-CH2CH3), 11.38 (s, C5(CH3)5); 31P-
{1H} NMR (C6D6) δ 48.14 (s). Anal. Calcd for C26H51NPTa: C,
52.96; H, 8.72; N, 2.38. Found: C, 52.58; H, 8.22; N, 2.23.
Preliminary X-ray data: P21/c a ) 8.7750(2) Å, b ) 14.6401-
(3) Å, c ) 21.6376(5) Å, â ) 90.564(1)°, Z ) 4.
- 90.26 (t, 19.4 Hz, 8F). 19: 1H NMR (CD2Cl2) δ 7.25 (t, |J H-H
|
) 7.5 Hz, 2H, Ta-CH2(C6H5)), 7.01 (t, |J H-H| ) 7.5 Hz, 1H, Ta-
CH2(C6H5)), 6.90 (d, |J H-H| ) 7.5 Hz, 2H, Ta-CH2(C6H5)), 3.40
(d, |J H-H| ) 14.4 Hz, 1H, Ta-CH2(C6H5)) 2.59 (d, |J H-H| ) 14.4
Hz, 1H, Ta-CH2(C6H5)) 2.20 (s, 15H, C5(CH3)5), 1.50 (d, |J P-H
|
) 14.7 Hz, 27H, PC(CH3)3); 13C{1H} NMR (CD2Cl2) δ 150-
135 (br, B(C6F5)4), 141.97, 130.69, 128.62, 126.25 (s, Ta-CH2-
(C6H5)), 125.45(s, C5(CH3)5), 78.61 (s, Ta-CH2(C6H5)) 42.60 (d,
|J P-C| ) 39.3 Hz, PC(CH3)3), 29.70 (s, PC(CH3)3), 12.22 (s, C5-
(CH3)5); 31P{1H} NMR (CD2Cl2) δ 72.13 (s); 11B NMR (CD2Cl2)
δ -2.64 (br); 19F NMR (CD2Cl2) δ -54.00 (s, 6F), -82.38 (s,
br, 3F), -88.58 (s, 6F).
Gen er a t ion /Syn t h esis of [Cp *Ta (NP t-Bu 3)Cl2]A (A )
[ClB(C6F 5)3]- 13, [B(C6F 5)4]- 14), Cp *Ta (NP R3)Me2(MeB-
(C6F5)3) (R ) t-Bu 15, i-P r 16), [Cp*Ta(NP R3)Me2][B(C6F5)4]
(R ) t-Bu 17, i-P r 18), [Cp *Ta (NP t-Bu 3)Bn Cl][ClB(C6F 5)3],
19. These compounds were generated in similar NMR experi-
ments using the appropriate neutral precursor and either
B(C6F5)3 or [Ph3C][B(C6F5)4]; thus only one preparation is
detailed. To a solution of 3 (33 mg, 0.057 mmol) in CH2Cl2 was
added [Ph3C][B(C6F5)4] (53 mg, 0.057 mmol). The solution was
stirred for 1 h, the solvent removed, and the residue washed
several times with hexanes. The solid was recrystallized to
give 17 in 68% yield. In cases where the products were only
generated in solution, the reactions were monitored by NMR
spectroscopy. The extreme sensitivity of these species pre-
cluded satisfactory elemental analysis; 1H NMR spectra of
these species have been deposited as supplementary data. 13:
1H NMR (CD2Cl2) δ 2.44 (s, 15H, C5(CH3)5), 1.57 (d, |J P-H| )
14.7 Hz, 27H, PC(CH3)3); 13C{1H} NMR (CD2Cl2) δ 150-130
(br, B(C6F5)3), 128.13 (s, C5(CH3)5), 43.17 (d, |J P-C| ) 37.8 Hz,
PC(CH3)3), 29.66 (s, PC(CH3)3), 12.64 (s, C5(CH3)5); 31P{1H}
Syn th esis of [Cp *Ta (NP t-Bu 3)(Cl)(CH2CH2CP h 3)]A (A
) [B(C6F 5)4] 20, BF 4 21). These compounds were generated
in similar NMR experiments using the appropriate neutral
precursor and either Ph3C[B(C6F5)4] or Ph3C[BF4]; thus only
one preparation is detailed. To a solution of 10 (30 mg, 0.050
mmol) in CD2Cl2 was added Ph3C[B(C6F5)4] (46 mg, 0.050
mmol). Evaporation of the solvent yielded the product in
quantitative yield. The extreme sensitivity of this species
precluded satisfactory elemental analysis; 1H NMR spectra of
these species have been deposited as supplementary data. 20:
1H NMR (CD2Cl2) δ 7.30-7.18 (m, 15H, CH2C(C6H5)3) 3.11 (m,
TaCH2CH2CPh), 2.90 (m, TaCH2CH2CPh) 2.22 (m, TaCH2CH2-
CPh), 2.12 (s, 15H, C5(CH3)5), 1.46 (d |J P-H| ) 14.4 Hz, 27H,
PC(CH3)3) 1. 02 (m, TaCH2CH2CPh); 13C{1H} NMR (CD2Cl2)
δ 146.72, 129.57, 128.38, 126.59 (s, CH2C(C6H5)3)) 124.88 (s,
C5(CH3)5), 70.65 (s, TaCH2CH2CPh), 62.48 (s, TaCH2CH2CPh),
42.72 (d, |J P-C| ) 14.1 Hz, PC(CH3)3), 42.29 (s, TaCH2CH2-
CPh), 29.74 (s PC(CH3)3), 12.13 (s, C5(CH3)5); 31P{1H} NMR
(CD2Cl2) 71.06 (s); 11B NMR (CD2Cl2) δ -22.88 (s); 19F NMR
NMR (CD2Cl2) δ 74.69 (s); 11B NMR (CD2Cl2) δ -0.16 (br); 19
F